On the other hand, the mutations unique to the HCC samples included somatic alterations in bona fide cancer driver genes such as MYCN (G46V) and MAP2K4 (Q118K)29 (Fig. 3b). The gene discussed is MAP2K4; the disease is hepatocellular carcinoma.